{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:22:16Z","timestamp":1790558536121,"version":"4.1.0"},"reference-count":67,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Over the last years, nontuberculous mycobacteria (NTM) have emerged as important human pathogens. Infections caused by NTM are often difficult to treat due to an intrinsic multidrug resistance for the presence of a lipid-rich outer membrane, thus encouraging an urgent need for the development of new drugs for the treatment of mycobacterial infections. Efflux pumps (EPs) are important elements that are involved in drug resistance by preventing intracellular accumulation of antibiotics. A promising strategy to decrease drug resistance is the inhibition of EP activity by EP inhibitors (EPIs), compounds that are able to increase the intracellular concentration of antimicrobials. Recently, attention has been focused on identifying EPIs in mycobacteria that could be used in combination with drugs. The aim of the present review is to provide an overview of the current knowledge on EPs and EPIs in NTM and also, the effect of potential EPIs as well as their combined use with antimycobacterial drugs in various NTM species are described.<\/jats:p>","DOI":"10.3390\/ijms21124191","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T03:17:32Z","timestamp":1592191052000},"page":"4191","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Efflux Pump Inhibitors against Nontuberculous Mycobacteria"],"prefix":"10.3390","volume":"21","author":[{"given":"Laura","family":"Rindi","sequence":"first","affiliation":[{"name":"Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Universit\u00e0 di Pisa, I-56127 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00038-17","article-title":"Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria","volume":"31","author":"Forbes","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.01408-18","article-title":"An Update on Mycobacterial Taxonomy, 2016\u20132017","volume":"57","author":"Parrish","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.5588\/ijtld.14.0120","article-title":"The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: A systematic review","volume":"18","author":"Brode","year":"2014","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: A review","volume":"36","author":"Prevots","year":"2014","journal-title":"Clin. Chest Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Donohue, M.J. (2018). Increasing nontuberculous mycobacteria reporting rates and species diversity identified in clinical laboratory reports. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3043-7"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1469-0691.2009.03014.x","article-title":"Clinical manifestations of nontuberculous mycobacteria infections","volume":"15","author":"Tortoli","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0033-1333569","article-title":"Diagnosis of Nontuberculous Mycobacterial Infections","volume":"34","year":"2013","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","article-title":"The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: An NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1513\/AnnalsATS.201412-559OC","article-title":"Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012","volume":"12","author":"Henkle","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Rindi, L., and Garzelli, C. (2015). Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1380-y"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wu, J., Zhang, Y., Li, J., Lin, S., Wang, L., Jiang, Y., Pan, Q., and Shen, X. (2014). Increase in Nontuberculous Mycobacteria Isolated in Shanghai, China: Results from a Population-Based Study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109736"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-0038-1660864","article-title":"Geographic Distribution of Nontuberculous Mycobacteria Isolated from Clinical Specimens: A Systematic Review","volume":"39","author":"Zweijpfenning","year":"2018","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/QCO.0b013e3283511a64","article-title":"Therapy of refractory nontuberculous mycobacterial lung disease","volume":"25","author":"Griffith","year":"2012","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.drup.2012.04.001","article-title":"Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria","volume":"15","author":"Boeree","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3389\/fmicb.2017.00681","article-title":"New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria","volume":"8","author":"Nasiri","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3389\/fmicb.2018.01613","article-title":"Challenges of NTM Drug Development","volume":"9","author":"Falkinham","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2011.00831.x","article-title":"Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis: Table 1","volume":"63","author":"Martin","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/AAC.05546-11","article-title":"The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance","volume":"56","author":"Schmalstieg","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1574-6976.2005.00002.x","article-title":"Role of mycobacterial efflux transporters in drug resistance: An unresolved question","volume":"30","author":"Riccardi","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/JB.180.22.5836-5843.1998","article-title":"Molecular Cloning and Characterization of Tap, a Putative Multidrug Efflux Pump Present in Mycobacterium fortuitum and Mycobacterium tuberculosis","volume":"180","author":"Blokpoel","year":"1998","journal-title":"J. Bacteriol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jac\/dki436","article-title":"Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum","volume":"57","author":"Martin","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1128\/AAC.48.7.2415-2423.2004","article-title":"Efflux Pump-Mediated Intrinsic Drug Resistance in Mycobacterium smegmatis","volume":"48","author":"Li","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1128\/AAC.00656-06","article-title":"LfrR Is a Repressor That Regulates Expression of the Efflux Pump LfrA in Mycobacterium smegmatis","volume":"50","author":"Buroni","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/acsinfecdis.5b00052","article-title":"Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium","volume":"1","author":"Machado","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"01000","DOI":"10.1128\/AAC.01316-18","article-title":"The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus","volume":"63","author":"Richard","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0924-8579(03)00208-5","article-title":"Mycobacterial efflux pumps and chemotherapeutic implications","volume":"22","author":"Viveiros","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijantimicag.2016.04.007","article-title":"Development of efflux pump inhibitors in antituberculosis therapy","volume":"47","author":"Song","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1586\/eri.12.89","article-title":"Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs","volume":"10","author":"Viveiros","year":"2012","journal-title":"Expert Rev. Anti-infect. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkv316","article-title":"Efflux pump inhibitors: Targeting mycobacterial efflux systems to enhance TB therapy","volume":"71","author":"Pule","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.drudis.2017.01.002","article-title":"Antituberculosis drugs: Reducing efflux = increasing activity","volume":"22","author":"Rodrigues","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/JCM.02087-16","article-title":"Emergence ofmmpT5Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease","volume":"55","author":"Alexander","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1128\/AAC.02509-16","article-title":"Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384","volume":"61","author":"Halloum","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Vianna, J.S., Machado, D., Ramis, I.B., Silva, F.P., Bierhals, D.V., Abril, M.A., Von Groll, A., Ramos, D.F., Louren\u00e7o, M.C., and Viveiros, M. (2019). The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin. Antibiotics, 8.","DOI":"10.3390\/antibiotics8030153"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2147\/IDR.S239850","article-title":"Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates","volume":"13","author":"Guo","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1128\/jb.178.13.3791-3795.1996","article-title":"Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump","volume":"178","author":"Liu","year":"1996","journal-title":"J. Bacteriol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1073\/pnas.93.1.362","article-title":"Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis","volume":"93","author":"Takiff","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1574-6968.2000.tb09396.x","article-title":"Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance","volume":"193","author":"Sander","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1128\/AAC.42.8.1931","article-title":"Molecular Cloning and Functional Analysis of a Novel Tetracycline Resistance Determinant, tet (V), from Mycobacterium smegmatis","volume":"42","author":"Blokpoel","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/JB.01724-12","article-title":"Characterization of the MSMEG_2631 Gene (mmp) Encoding a Multidrug and Toxic Compound Extrusion (MATE) Family Protein in Mycobacterium smegmatis and Exploration of Its Polyspecific Nature Using Biolog Phenotype MicroArray","volume":"195","author":"Mishra","year":"2013","journal-title":"J. Bacteriol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zhang, H., Gao, L., Zhang, J., Li, W., Yang, M., Zhang, H., Gao, C.-H., and He, Z. (2014). A Novel marRAB Operon Contributes to the Rifampicin Resistance in Mycobacterium smegmatis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106016"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jac\/dkn070","article-title":"Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis","volume":"61","author":"Rodrigues","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijantimicag.2009.07.010","article-title":"The role of efflux pumps in macrolide resistance in Mycobacterium avium complex","volume":"34","author":"Rodrigues","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejmech.2017.09.014","article-title":"Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium","volume":"140","author":"Cannalire","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/acsinfecdis.9b00041","article-title":"Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants","volume":"5","author":"Felicetti","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41429-019-0245-1","article-title":"Effect of efflux pump inhibitors on the susceptibility of Mycobacterium avium complex to clarithromycin","volume":"73","author":"Menichini","year":"2019","journal-title":"J. Antibiot."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1055\/a-0639-5412","article-title":"Antimicrobial and Efflux Inhibitor Activity of Usnic Acid Against Mycobacterium abscessus","volume":"84","author":"Ramis","year":"2018","journal-title":"Planta Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"101853","DOI":"10.1016\/j.tube.2019.07.004","article-title":"In silico and in vitro evaluation of tetrahydropyridine compounds as efflux inhibitors in Mycobacterium abscessus","volume":"118","author":"Ramis","year":"2019","journal-title":"Tuberculosis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jgar.2018.12.020","article-title":"Tetrahydropyridine derivative as efflux inhibitor in Mycobacterium abscessus","volume":"17","author":"Vianna","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.phytol.2008.01.002","article-title":"Modulation of isoniazid susceptibility by flavonoids in Mycobacterium","volume":"1","author":"Lechner","year":"2008","journal-title":"Phytochem. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Solnier, J., Martin, L., Bhakta, S., and Bucar, F. (2020). Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species. Molecules, 25.","DOI":"10.3390\/molecules25030734"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.3390\/molecules15117750","article-title":"Farnesol, a Potential Efflux Pump Inhibitor in Mycobacterium smegmatis","volume":"15","author":"Jin","year":"2010","journal-title":"Molecules"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Rodrigues, L., Ramos, J., Couto, I., Amaral, L., and Viveiros, M. (2011). Ethidium bromide transport across Mycobacterium smegmatis cell-wall: Correlation with antibiotic resistance. BMC Microbiol., 11.","DOI":"10.1186\/1471-2180-11-35"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An Official ATS\/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1099\/ijsem.0.003026","article-title":"A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review","volume":"68","author":"Turenne","year":"2018","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1128\/JCM.43.9.4407-4412.2005","article-title":"Clinical Significance and Epidemiologic Analyses of Mycobacterium avium and Mycobacterium intracellulare among Patients without AIDS","volume":"43","author":"Han","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/1568005023342263","article-title":"Natural and Acquired Macrolide Resistance in Mycobacteria","volume":"2","year":"2002","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/mmi.13675","article-title":"The diverse family of MmpL transporters in mycobacteria: From regulation to antimicrobial developments","volume":"104","author":"Viljoen","year":"2017","journal-title":"Mol. Microbiol."},{"key":"ref_58","first-page":"733","article-title":"The in vitro activity of phenothiazines against Mycobacterium avium: Potential of thioridazine for therapy of the co-infected AIDS patient","volume":"19","author":"Viveiros","year":"2005","journal-title":"In Vivo"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/AAC.02985-15","article-title":"Thioridazine as chemotherapy for Mycobacterium avium complex ciseases","volume":"60","author":"Deshpande","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Costa, S.S., Falc\u00e3o, C., Viveiros, M., Machado, D., Martins, M., Cristino, J.M., Amaral, L., and Couto, I. (2011). Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus. BMC Microbiol., 11.","DOI":"10.1186\/1471-2180-11-241"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1099\/ijsem.0.001376","article-title":"Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov.","volume":"66","author":"Tortoli","year":"2016","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A Novel Gene, erm (41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but is Absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/13880200903085490","article-title":"Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria","volume":"48","author":"Ramos","year":"2010","journal-title":"Pharm. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1128\/AAC.49.11.4775-4777.2005","article-title":"mmpL7 Gene of Mycobacterium tuberculosis is Responsible for Isoniazid Efflux in Mycobacterium smegmatis","volume":"49","author":"Pasca","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jac\/dkn178","article-title":"Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis","volume":"62","author":"Lechner","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1099\/jmm.0.025734-0","article-title":"The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis","volume":"60","author":"Jin","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijantimicag.2009.06.026","article-title":"Detection of lfrA and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteria","volume":"34","author":"Esteban","year":"2009","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/12\/4191\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:38:08Z","timestamp":1760175488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/12\/4191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":67,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["ijms21124191"],"URL":"https:\/\/doi.org\/10.3390\/ijms21124191","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]}}}